Diffuse hepatocellular carcinoma with extension into the right atrium

doi:10.15406/jcpcr.2021.12.00474

Journal of

eISSN: 2373-633X

Cancer Prevention & Current Research

Case Report Volume 12 Issue 6

Diffuse hepatocellular carcinoma with extension into the right atrium

Jennifer Richardson,¹

Verify Captcha

Regret for the inconvenience: we are taking measures to prevent fraudulent form submissions by extractors and page crawlers. Please type the correct Captcha word to see email ID.

Saray Serrano,² Marco Luján³

¹Radiology Resident, Faculty of Medicine, Universidad del Norte, Colombia
²Medical Radiologist, Cediul S.A., Colombia
³Medical Hepatologist, Clínica de la Costa, Colombia

Correspondence: Jennifer Richardson, Radiology Resident, Faculty of Medicine, Universidad del Norte, Barranquilla, Colombia

Received: November 09, 2021 | Published: December 6, 2021

Citation: Richardson J, Serrano S, Luján M. Diffuse hepatocellular carcinoma with extension into the right atrium. J Cancer Prev Curr Res. 2021;12(6):167-169. DOI: 10.15406/jcpcr.2021.12.00474

Download PDF

Abstract

Hepatocellular carcinoma is one of the diagnoses that we most frequently see in our clinical practice, accustomed to seeing it as a single lesion, many do not know the diffuse subtype whose involvement and extension are rare. In this article, we present a case of diffuse hepatocarcinoma with cardiac extension and we discuss the importance of recognizing it because its management and prognosis depend on it.

Keywords: carcinoma hepatocelular, liver neoplasms, magnetic resonance imaging

Introduction

Primary hepatic carcinoma represents the second leading cause of cancer mortality and is the fifth most prevalent tumor,¹ with hepatocellular carcinoma (HCC) as the most common histological type accounting for 90% of these lesions.² It is a multicausal pathology secondary to genetic changes favored by chronic liver disease, cirrhosis, hepatitis B and C virus infection, excessive alcohol consumption, obesity, metabolic syndrome, non-alcoholic hepatic steatosis, smoking, hemochromatosis, type 2 diabetes mellitus, Wilson's disease, congenital biliary atresia, and aflatoxins. The coexistence of these diseases increases the incidence of the tumor.³ According to its growth pattern, it is classified into: nodular (multifocal), massive (focal), and infiltrative (diffuse).⁴

Clinical scenario

A 48-year-old male patient, with a history of liver cirrhosis due to hepatitis B and alcoholism, consults for an increase in the abdominal perimeter that hinders food intake. To the physical examination with abdominal distension. In blood biochemistry, alpha-fetal high protein of 500 ng/ml stands out. In the cardiac and simple abdominal magnetic resonance with contrast, in which a cirrhotic liver with a hypervascular lesion, irregular heterogeneous lesion in segment VIII, is observed, it measures approximately 6 x 4.8 x 3.7 cms (Figure 1A). It presents late-stage washing with capsular enhancement (Figure 1B). In addition, the lesion invades the portal vein with tumor thrombus (Figure 2), and inferior cava extending to the right atrium (Figure 3), where it occupies more than 50% of it with valvular contact (Figure 4). These findings are related to diffuse hepatocellular carcinoma with metastatic involvement.

Figure 1 Description: Axial magnetic resonance imaging in T1W. Hepatocarcinoma in segment VIII with serpentiginous enhancement inside in relation to intratumor neoformation (A), and enhancement of its capsule in late phases (B). Note the dilation of the intrahepatic bile duct (green arrow).
Origin: Department of Radiology, Clínica de la Costa, Barranquilla, Colombia, 2019.

Figure 2 Description: Late-stage post-contrast coronal magnetic resonance imaging in T1W. Tumor thrombus that enhances in the venous phase and expands the inferior vena cava (arrow).
Origin: Department of Radiology, Clínica de la Costa, Barranquilla, Colombia, 2019.

Figure 3 Description: Sagittal magnetic resonance imaging in T2W (A) and T1W (B). Hepatocarcinoma extends through the inferior vena cava to the right atrium, invading more than 50% and in contact with the atrioventricular leaflets. Origin: Department of Radiology, Clínica de la Costa, Barranquilla, Colombia, 2019.

Figure 4 Description: Axial magnetic resonance T1W Fatsat (A) and T2W cinema post-contrast. Extensive atrial involvement due to metastatic tumor invasion. Right pleural effusion (green arrow) is also observed. Origin: Department of Radiology, Clínica de la Costa, Barranquilla, Colombia, 2019.

Discussion

Hepatocarcinoma with diffuse subtype is a rare diagnosis with few reviews in the literature, corresponding to approximately 7-13% of cases of hepatocellular carcinoma.⁴ As for tumor markers, some studies have shown that alpha-fetal protein (AFP) is a highly specific parameter, with high protein values (> 400 ng/ml, check your laboratory reference values), with a low sensitivity of 54%. This indicates that we should pay special attention to elevated AFP values, while low values do not exclude the diagnosis of hepatocellular carcinoma.⁶

Diffuse hepatocellular carcinoma has an infiltrating behavior, therefore, in the image, an alteration in the intensity of the homogeneous or heterogeneous variable signal is observed. Magnetic resonance imaging (MRI) shows:^7,8

Predominantly hypointense lesion in T1 and T2 varies from hypo to isointense.
After administration of the contrast medium, a "miliar" pattern is identified
Dynamic post-contrast images with heterogeneous areas of enhancement in early phases and "washing" in later phases.
Restriction on dissemination.
There is a high prevalence of portal vein thrombosis in patients with HCC, with unique characteristics in the diffuse subtype, given by an invasion pattern with marked distension of the vein which as it infiltrates the adjacent vessels acquires an image of molding of these.⁶
In the portal phase, the portal thrombus is observed as a filling defect.

Differential imaging diagnoses include cholangiocarcinoma, atrial myxoma, and cardiac angiosarcoma. Patients with diffuse hepatocellular carcinoma have a poor prognosis in relation to the late stage of presentation and diagnosis. This subtype is a contraindication to resection or transplantation, with transcatheter chemo-embolization as the only therapeutic option for these patients.⁸